Equity Distribution for IONIS PHARMACEUTICALS Inc
Ticker | IONS |
FIGI | BBG000JH6683 |
CUSIP | 462222100 |
Sector | Healthcare |
Equity Type | Common Stock |
No. Companies Holding this Equity | 334 / 4.8% |
Percentage held by institutional investors | 99.4% |
About
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza (Nusinersen), Tegsedi (Inotersen), and Waylivra (Volanesorsen) and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO(a)-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.The company was named Isis Pharmaceuticals until December 2015. Wikipedia